International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 419-420, May 2010

Therapeutic drug monitoring of β-lactams for critically ill patients: unwarranted or essential?

  • Jason A. Roberts

      Affiliations

    • Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia
    • Department of Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • Pharmacy Department, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • Corresponding Author InformationCorresponding author. Present address: Burns, Trauma and Critical Care Research Centre, Level 3 Ned Hanlon Building, Royal Brisbane and Women's Hospital, Butterfield Street, Brisbane, Queensland 4029, Australia.
  • Jeffrey Lipman

      Affiliations

    • Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia
    • Department of Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Australia

The University of Manchester, Manchester Academic Health Science Centre, NIHR Translational Research Facility in Respiratory Medicine, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK

published online 02 March 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-8579(10)00067-1

doi:10.1016/j.ijantimicag.2010.01.022

International Journal of Antimicrobial Agents
Volume 35, Issue 5 , Pages 419-420, May 2010

Article Tools